Last updated: March 2026
Methylene blue is a 140-year-old compound — first synthesized in 1876 as a textile dye — that became the first synthetic drug ever used in humans (for malaria, 1891). FDA-approved for three conditions, it is now actively studied for Alzheimer's, Parkinson's, and cognitive enhancement, with preclinical data showing it increases mitochondrial Complex IV activity by 30%.
The story of methylene blue is one of the most remarkable origin stories in pharmacology — a compound that started in a dye factory and ended up shaping modern psychiatry.
"Methylene blue was literally the first synthetic drug ever used in humans. It spawned an entire class of antidepressants. And now, 140 years later, researchers are discovering it might be even more useful than anyone imagined."
MB's effects aren't magic — they're rooted in four distinct, well-studied mechanisms that make it unlike any other nootropic compound.
MB's mitochondrial mechanisms have made it a compelling target for neuroprotection research across several major conditions. The common thread: nearly all neurodegeneration involves mitochondrial dysfunction.
Evidence transparency: Most neuroprotection data is from animal studies. The Alzheimer's trials (LMTX) are the main human evidence — with mixed but promising results showing brain atrophy reduction. Each card below is labeled by evidence level.
The neuroprotection research is compelling. But what about healthy people looking for cognitive enhancement? Here's what the evidence actually shows.
Here's the part nobody expects when they first try methylene blue.
Methylene blue temporarily turns your tongue blue for about 24 hours. But here's the fascinating part — if it DOESN'T turn your tongue blue, that's actually a signal your mitochondria aren't working optimally.
When your mitochondria are functioning well, they rapidly reduce MB from its blue form to its colorless form (leucomethylene blue). Poorly functioning mitochondria can't perform this reduction efficiently, so the blue color persists longer or is more pronounced.
— Craig Koniver, Huberman Lab
⚠️ Not a validated diagnostic testThis is an observation from clinical practice, not a validated biomarker. The science of mitochondrial reduction of MB is real — the interpretation as a "mitochondrial health test" is informal. Don't make clinical decisions based on tongue color. But it's a fascinating window into redox biology.
Critical principle: MB follows a hormetic dose-response curve. LOW doses enhance mitochondrial function. HIGH doses can INHIBIT it. More is emphatically NOT better with methylene blue.
MB has a legitimate 140+ year safety record at therapeutic doses. But it has one drug interaction that can be fatal, and you need to understand it before ever taking methylene blue.
MB is a potent MAO inhibitor. Combining it with SSRIs, SNRIs, or other serotonergic drugs can cause SEROTONIN SYNDROME — a potentially fatal condition characterized by high fever, rapid heart rate, muscle rigidity, and in severe cases, death. This is not a theoretical risk. It has caused hospitalizations.
Do NOT combine methylene blue with:
G6PD Deficiency: Glucose-6-phosphate dehydrogenase deficiency is more common than most people realize (affects ~400 million people globally). In G6PD-deficient individuals, MB can trigger hemolytic anemia — a serious condition where red blood cells break down. Get tested before starting MB if you're in a higher-risk group (Mediterranean, African, Asian ancestry).
Both target mitochondrial function, but through completely different mechanisms. Here's how they compare — and why some biohackers stack them.
"Both target mitochondria but through different mechanisms. MB optimizes the electron transport chain while NAD+ provides the raw fuel. Some biohackers use both — think of MB as tuning the engine and NAD+ as filling the tank."
The bottom line on methylene blue — what the evidence supports, and what you need to be careful about.
What you need for methylene blue supplementation
Affiliate links help support MeetPeptide at no extra cost to you.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
⚕️ Educational purposes only. Methylene blue is an FDA-approved drug for specific conditions including methemoglobinemia, ifosfamide encephalopathy, and vasoplegic syndrome. Off-label nootropic use is not FDA-approved and has not been evaluated by the FDA for this purpose. This content does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or supplement. NEVER combine methylene blue with serotonergic medications (SSRIs, SNRIs, MAOIs) — this combination can cause life-threatening serotonin syndrome.